statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
NA - Nord America	6.443
EU - Europa	4.050
AS - Asia	4.027
SA - Sud America	443
AF - Africa	94
OC - Oceania	13
Continente sconosciuto - Info sul continente non disponibili	2
Totale	15.072

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.241
IT - Italia	2.420
SG - Singapore	1.769
CN - Cina	829
HK - Hong Kong	600
BR - Brasile	377
VN - Vietnam	371
GB - Regno Unito	286
FR - Francia	250
DE - Germania	213
RU - Federazione Russa	179
FI - Finlandia	165
IE - Irlanda	156
IN - India	107
CA - Canada	104
UA - Ucraina	91
TR - Turchia	78
MX - Messico	77
BD - Bangladesh	72
SE - Svezia	72
JP - Giappone	47
AT - Austria	39
PL - Polonia	39
NL - Olanda	36
IQ - Iraq	28
ES - Italia	27
ZA - Sudafrica	26
AR - Argentina	25
NG - Nigeria	23
SA - Arabia Saudita	21
BE - Belgio	18
LT - Lituania	18
CH - Svizzera	11
KE - Kenya	11
PK - Pakistan	11
AE - Emirati Arabi Uniti	10
AU - Australia	10
MY - Malesia	10
MA - Marocco	9
UZ - Uzbekistan	9
CO - Colombia	8
ID - Indonesia	8
JO - Giordania	8
VE - Venezuela	8
EC - Ecuador	7
AZ - Azerbaigian	6
CL - Cile	6
PH - Filippine	6
TN - Tunisia	6
EG - Egitto	5
IL - Israele	5
MD - Moldavia	5
PE - Perù	5
BB - Barbados	4
ET - Etiopia	4
GR - Grecia	4
KR - Corea	4
LB - Libano	4
TT - Trinidad e Tobago	4
BH - Bahrain	3
CI - Costa d'Avorio	3
CR - Costa Rica	3
GT - Guatemala	3
NO - Norvegia	3
UY - Uruguay	3
BG - Bulgaria	2
BY - Bielorussia	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
EE - Estonia	2
EU - Europa	2
GE - Georgia	2
IR - Iran	2
KH - Cambogia	2
KZ - Kazakistan	2
NP - Nepal	2
PA - Panama	2
PY - Paraguay	2
QA - Qatar	2
RS - Serbia	2
RW - Ruanda	2
SI - Slovenia	2
TH - Thailandia	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AO - Angola	1
BN - Brunei Darussalam	1
BO - Bolivia	1
BZ - Belize	1
CG - Congo	1
CY - Cipro	1
GA - Gabon	1
GN - Guinea	1
GY - Guiana	1
HN - Honduras	1
IM - Isola di Man	1
JM - Giamaica	1
KG - Kirghizistan	1
NC - Nuova Caledonia	1
NI - Nicaragua	1
Totale	15.063

Salva come PNG Salva come JPEG

Città	#
Milan	1.425
San Jose	1.166
Singapore	938
Ashburn	656
Hong Kong	589
Council Bluffs	461
Dallas	455
Chicago	443
Beijing	293
The Dalles	243
Boardman	214
Lauterbourg	179
London	176
Los Angeles	165
Dublin	151
Fairfield	141
Rome	138
Ho Chi Minh City	109
Helsinki	107
Varese	105
Chandler	94
New York	93
Hanoi	84
Seattle	81
Santa Clara	77
Jacksonville	73
Munich	71
Como	60
Houston	59
Salt Lake City	57
Woodbridge	55
Frankfurt am Main	52
Wilmington	52
Mexico City	49
Ogden	49
Washington	44
Chennai	43
Brooklyn	42
Ann Arbor	41
Tokyo	40
Toronto	40
Orem	38
Nyköping	35
Warsaw	34
São Paulo	33
Cambridge	32
Tampa	32
Guangzhou	31
Princeton	30
Vienna	29
Atlanta	27
Izmir	26
Magnago	26
Nuremberg	26
Montreal	25
Denver	24
Elk Grove Village	24
Lancaster	24
Abuja	23
Boston	23
Dearborn	23
Da Nang	22
Phoenix	21
San Francisco	21
Shanghai	21
Johannesburg	20
Buffalo	18
San Diego	18
Shenzhen	18
Amsterdam	17
Brussels	17
Haiphong	16
West Jordan	16
Rio de Janeiro	15
Dhaka	14
Stockholm	14
Belo Horizonte	13
Lappeenranta	13
Poplar	13
Vancouver	13
Ankara	12
Assago	12
Manchester	12
Mumbai	12
New Delhi	12
Turku	12
Nairobi	11
Pune	11
Sterling	11
Charlotte	10
Hangzhou	10
Baghdad	9
Detroit	9
Dulles	9
Düsseldorf	9
Jeddah	9
Miami	9
Pittsburgh	9
Berlin	8
Dong Ket	8
Totale	10.499

Salva come PNG Salva come JPEG

Nome	#
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	479
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	195
Coronaviridae and SARS-associated coronavirus strain HSR1.	194
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	186
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	181
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	181
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	171
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	164
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	163
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	160
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	159
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	159
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	140
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	136
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	131
A biologically-validated HCV E1E2 heterodimer structural model	121
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	117
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	114
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	114
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	113
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	111
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota	111
Type III interferons disrupt the lung epithelial barrier upon viral recognition	111
Phage display for the production of human monoclonal antibodies against human pathogens.	111
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	109
Humoral immune response against hepatitis C virus.	108
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	106
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	106
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	105
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	104
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	104
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	104
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	103
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	101
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	101
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	100
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	98
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	98
The IN SIGNO project: Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	98
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	96
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	96
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	96
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	96
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	93
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	91
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era	91
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	91
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	90
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	90
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	89
Answer to photo quiz: Streptococcus pneumoniae	88
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	87
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	87
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	87
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	87
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	86
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	86
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience	86
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	86
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	85
The interferon landscape along the respiratory tract impacts the severity of COVID-19	85
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	84
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	84
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	84
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	83
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	83
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	83
A closer look at prion strains: characterization and important implications	82
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023	82
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	82
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition	81
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	81
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	80
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023	79
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	79
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	79
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	78
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	77
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	77
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	77
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates	76
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	76
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	76
Viral respiratory pathogens and lung Injury	76
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	75
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	74
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	73
Risks of "blind" automated identification systems in medical microbiology	72
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	71
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	71
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	71
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	71
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	71
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects	70
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	70
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	70
Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform	70
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	70
A family cluster of Streptococcus pyogenes associated with a fatal early-onset neonatal sepsis	69
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	69
Totale	10.312

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	78.988
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	78.988

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	25	0	0	0	0	0	0	0	0	0	0	0	25
2021/2022	219	11	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	3.254	24	58	629	141	102	159	134	134	353	184	465	871
2025/2026	8.000	594	409	616	987	541	292	1.857	436	961	550	455	302
Totale													15.572